Literature DB >> 17895057

Accelerated bone remodeling in patients with poststroke hemiplegia.

Y Sato1, Y Fujimatsu, Y Honda, H Kunoh, M Kikuyama, K Oizumi.   

Abstract

A significant bone-mass reduction occurs on the hemiplegic side of stroke patients because of disuse and vitamin D deficiency. This may explain why hip fractures in poststroke patients occur almost exclusively on the hemiplegic side. To further evaluate this osteopenia, bone mineral density (BMD) in both second metacarpals was assessed in 61 patients and 28 control subjects. Serum concentrations of intact parathyroid hormone (PTH), osteocalcin (OC), tartrate-resistant acid phosphatase (TRAP), 25-hydroxyvitamin D (25-OHD), and calcium also were determined. The patients' BMD values were higher on the hemiplegic side than on the nonhemiplegic side. BMD on the hemiplegic side correlated positively with serum concentrations of PTH, OC and TRAP, which exceeded those in control subjects. Serum 25-OHD was low in patients, correlating negatively with BMD on the hemiplegic side. Serum PTH correlate positively with the levels of OC and TRAP and negatively with 25-OHD concentrations. The results indicate that skeletal remodeling is accelerated in patients with hemiplegia, with resorption predominating. We concluded that vitamin D deficiency and compensatory secondary hyperparathyroidism stimulating skeletal turnover is an important cause of osteopenia in the hemiplegic limbs of stroke patients. This osteopenia might be corrected by administration of etidronate to inhibit osteoclastic bone resorption together with a vitamin D supplement.

Entities:  

Year:  1998        PMID: 17895057     DOI: 10.1016/s1052-3057(98)80022-0

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  2 in total

1.  Poststroke hip fracture: prevalence, clinical characteristics, mineral-bone metabolism, outcomes, and gaps in prevention.

Authors:  Alexander Fisher; Wichat Srikusalanukul; Michael Davis; Paul Smith
Journal:  Stroke Res Treat       Date:  2013-09-25

2.  Osteocalcin improves outcome after acute ischemic stroke.

Authors:  Jiayan Wu; Yunxiao Dou; Wangmi Liu; Yanxin Zhao; Xueyuan Liu
Journal:  Aging (Albany NY)       Date:  2020-01-05       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.